Table 2.

Univariate and multivariate analysis of disease-free survival in 236 CRC patients

	Disease-free survival
	Univariate analysis		Multivariate analysis
	HR (95% CI)	p Value	HR (95% CI)	p Value
Age (yr)	0.871 (0.476–1.595)	0.655
Gender	1.153 (0.628–2.117)	0.646
Tumor location	0.997 (0.816–1.220)	0.980
T classification	2.636 (1.415–4.911)	0.002*	2.773 (1.238–6.211)	0.013*
N classification	2.514 (1.480–3.136)	< 0.001*	0.744 (0.415–1.334)	0.007*
M classification	6.733 (3.281–13.815)	< 0.001*	9.195 (3.931–21.504)	< 0.001*
AJCC stage (III -IV vs I- II)	6.160 (2.593–14.635)	< 0.001*	3.968 (1.203–130.90)	0.024*
Recurrence	7.689 (4.112–14.375)	< 0.001*	7.422 (3.701–14.884)	< 0.001*
Differentiation	0.666 (0.368–1.206)	0.180
AGGF1	3.956 (2.179–7.182)	< 0.001*	3.268 (1.779–6.002)	< 0.001*

HR: hazard ratio; CI: confidence interval

* Significant differences